HPV VLPs: Nature ’ s Nanoparticles for Prevention and Treatment of Cancer

NCI ’ s Center for Cancer Research (CCR) Grand Rounds Dr. John Schiller graduated from the University of Wisconsin-Madison with a B.S. in molecular biology in 1975. In 1982, he received a Ph.D. from the Department of Microbiology of the University of Washington in Seattle, then joined the NCI Laboratory of Cellular Oncology as a National Research Service Award postdoctoral fellow in 1983. Dr. Schiller became a senior staff fellow in the Laboratory of Cellular Oncology in 1986 and a senior investigator in 1992. He became chief of the Neoplastic Disease Section of the lab in 1998, deputy lab chief in 2000 and designated as an NIH Distinguished Investigator in 2016. Dr. Schiller has received numerous awards for his contributions to papillomavirus virus molecular biology and human papillomavirus (HPV) vaccine development, including the 2007 Service to America Medal – Federal Employee of the Year; the 2011 Albert Sabin Gold Medal Award; the 2011 AACR-American Cancer Society Award for Research Excellence in Cancer Epidemiology and Prevention; the 2014 National Medal of Technology and Innovation; and the 2017 American Society for Microbiology ’ s Joseph Public Health Award. Along with his colleague Dr. Douglas Lowy, Dr. Schiller received the 2017 Lasker-DeBakey Clinical Medical Research Award for groundbreaking research leading to the development of HPV vaccines.Air date: 2/9/2018 12:00:00 PM
Source: Videocast - All Events - Category: General Medicine Tags: Upcoming Events Source Type: video